A Closer Look At Shire PLC

In this video, we  put Shire‘s (LSE: SHP) deal with AbbVie (NYSE: ABBV) under the spotlight. For each share they held in Shire, investors will receive a cash consideration of £24.44 as well as 0.8960 new AbbVie shares. Here, two Fools look at whether investors should jump into either — or neither — of the pharmaceutical companies.

Fellow pharmaceutical GlaxoSmithKline is one of five shares in the FTSE 100 that our top analysts have highlighted in our special report "5 Shares To Retire On". To find out the reasons behind their inclusion, and the names of the other four shares, simply click here to have it delivered competely free to your inbox.

Neither Nate nor Mark own shares in any company mentioned.